<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>Diabetes Information and Treatment</title><link href="diabetesinfoandtreatment.com" rel="alternate"></link><id>diabetesinfoandtreatment.com</id><updated>2010-09-03T09:30:09Z</updated><entry><title>Protein test ups diabetes diagnoses in some races</title><link href="http://diabetesinfoandtreatment.com/diabetes/protein-test-ups-diabetes-diagnoses-races-1037881a" rel="alternate"></link><updated>2010-09-03T09:30:09Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-09-03:/diabetes/protein-test-ups-diabetes-diagnoses-races-1037881a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;NEW YORK&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;&lt;/span&gt;) - Efforts to adopt a more accurate test for diagnosing diabetes may have hit a snag. Comparing the age-old oral glucose tolerance test to the newer hemoglobin A1c test confirms earlier evidence that race may influence test results, Danish researchers report. "The prevalence of diabetes differed considerably according to diagnostic method," they write in the &lt;span&gt;&lt;a title...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Social Issues"></category><category term="Racial Issues"></category><category term="African-American Issues"></category><category term="Reuters Group plc"></category><category term="Nordic Countries"></category><category term="Greenland"></category><category term="Institute of Public"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Diabetes drug fights lung cancer in mice: study</title><link href="http://diabetesinfoandtreatment.com/diabetes/diabetes-drug-fights-lung-cancer-mice-study-1035908a" rel="alternate"></link><updated>2010-09-01T22:31:12Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-09-01:/diabetes/diabetes-drug-fights-lung-cancer-mice-study-1035908a</id><summary type="html">&lt;div&gt;&lt;p&gt;A popular drug that is used by millions of diabetics around the world significantly decreases tobacco-induced lung tumors in mice, a study published Wednesday found. Researchers led by &lt;span&gt;Philip Dennis&lt;/span&gt;, a senior investigator at the &lt;span&gt;&lt;a title="National Cancer Institute" href="/topic/National+Cancer+Institute" &gt;National Cancer Institute (NCI)&lt;/a&gt;&lt;/span&gt;, gave the diabetes drug metformin to mice which had been exposed to a carcinogen derived from nicotine. Mice treated orally...</summary><category term="Cancer"></category><category term="Lung Cancer"></category><category term="Health Care Issues"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Western Europe"></category><category term="Smoking and Tobacco Use"></category></entry><entry><title>Proposed diabetes test misses most cases: study</title><link href="http://diabetesinfoandtreatment.com/prediabetes/proposed-diabetes-test-misses-cases-study-1034525a" rel="alternate"></link><updated>2010-08-31T12:30:18Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-31:/prediabetes/proposed-diabetes-test-misses-cases-study-1034525a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;NEW YORK&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;&lt;/span&gt;) - A new proposed diabetes test could miss millions of cases of diabetes and pre-diabetes and also over-diagnose black Americans if it was used as a screening tool, suggests a new study. Over 23 million Americans have diabetes - about 8 percent of the population - and another 57 million are at risk for developing diabetes, according to the &lt;span&gt;&lt;a title="American Diabetes...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Prediabetes"></category><category term="Reuters Group plc"></category></entry><entry><title>Insulin resistance, type 2 diabetes linked to Alzheimer's</title><link href="http://diabetesinfoandtreatment.com/type-2-diabetes/insulin-resistance-type-2-diabetes-linked-alzheimers-1029423a" rel="alternate"></link><updated>2010-08-25T16:02:04Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-25:/type-2-diabetes/insulin-resistance-type-2-diabetes-linked-alzheimers-1029423a</id><summary type="html">&lt;div&gt;&lt;p&gt;People with insulin resistance and type 2 diabetes are at higher risk of developing plaques associated with Alzheimer's, Japanese researchers said in a study out Wednesday. The research, published in the &lt;a title="American Academy of Neurology" href="/topic/American+Academy+of+Neurology" &gt;American Academy of Neurology&lt;/a&gt;, involved 135 people with an average age of 67 from Hisayama, &lt;a title="Japan" href="/topic/Japan" &gt;Japan&lt;/a&gt;. The group was tested for blood sugar levels and followed ...</summary><category term="Geriatric Medicine"></category><category term="Alzheimer's Disease"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Prediabetes"></category><category term="Type 2 Diabetes"></category><category term="Obesity"></category><category term="East Asia"></category><category term="American Academy of Neurology"></category><category term="Fukuoka"></category><category term="Kyushu University"></category><category term="Brain and Nerve Health"></category><category term="Body Weight"></category><category term="Kensuke Sasaki"></category></entry><entry><title>Insulin resistance may cause Alzheimer plaques</title><link href="http://diabetesinfoandtreatment.com/type-2-diabetes/insulin-resistance-alzheimer-plaques-1029367a" rel="alternate"></link><updated>2010-08-25T15:46:26Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-25:/type-2-diabetes/insulin-resistance-alzheimer-plaques-1029367a</id><summary type="html">&lt;div&gt;&lt;p&gt;HONG KONG (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - People with insulin resistance and type 2 diabetes are more likely to develop plaques in the brain associated with Alzheimer's disease, researchers in &lt;a title="Japan" href="/topic/Japan" &gt;Japan&lt;/a&gt; reported on Thursday. The study involved 135 elderly participants in the town of Hisayama, &lt;a title="Fukuoka Prefecture" href="/topic/Fukuoka+Prefecture" &gt;Fukuoka prefecture&lt;/a&gt;, who had their blood sugar ...</summary><category term="Geriatric Medicine"></category><category term="Alzheimer's Disease"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Diabetes Symptoms"></category><category term="Prediabetes"></category><category term="Type 2 Diabetes"></category><category term="Reuters Group plc"></category><category term="East Asia"></category><category term="Fukuoka Prefecture"></category><category term="Fukuoka"></category><category term="Kyushu University"></category><category term="Tan Ee Lyn"></category><category term="Brain and Nerve Health"></category></entry><entry><title>Diabetes research pioneer William Kirtley dies, 96</title><link href="http://diabetesinfoandtreatment.com/diabetes/diabetes-research-pioneer-william-kirtley-dies-96-1029293a" rel="alternate"></link><updated>2010-08-25T15:30:54Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-25:/diabetes/diabetes-research-pioneer-william-kirtley-dies-96-1029293a</id><summary type="html">&lt;div id="subtitle"&gt;Diabetes research pioneer &lt;a title="William Kirtley" href="/topic/William+Kirtley" &gt;William R. Kirtley&lt;/a&gt; dies at 96, helped pioneer groundbreaking drugs&lt;/div&gt;&lt;div&gt;&lt;p&gt;Dr. William R. Kirtley, a medical researcher pioneer who helped develop drugs after World War II that greatly improved the lives of diabetics, has died at age 96. Jane Kirtley said her father died Sunday at a hospital near his &lt;a title="Hilton Head Island" href="/topic/Hilton+Head+Island" &gt;Hilton Head Island&lt;/a&gt;...</summary><category term="Obituaries"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Hilton Head Island"></category><category term="William Kirtley"></category><category term="Jane Kirtley"></category></entry><entry><title>Study links Chinese kidney problems to genes</title><link href="http://diabetesinfoandtreatment.com/diabetes/study-links-chinese-kidney-problems-genes-1029029a" rel="alternate"></link><updated>2010-08-25T09:15:45Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-25:/diabetes/study-links-chinese-kidney-problems-genes-1029029a</id><summary type="html">&lt;div&gt;&lt;p&gt;Variants of a gene contribute to the high risk of kidney disease among diabetics of Chinese descent compared with Caucasians, a study said Wednesday. Asians tend to have a higher likelihood of kidney failure, a major cause of death among diabetics. Diabetes rates have been soaring in &lt;a title="China" href="/topic/China" &gt;China&lt;/a&gt; as rising prosperity changes lifestyles. Writing in the &lt;a title="Journal of the American Medical Association" href="/topic/Journal+of+the+American+Medical+Ass...</summary><category term="Kidney Failure"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Kidney and Urologic Health"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Journal of the American Medical Association"></category><category term="East Asia"></category><category term="The Chinese University of Hong Kong"></category><category term="Ronald C.W"></category></entry><entry><title>Diabetes drug Avandia just as safe as Actos: study</title><link href="http://diabetesinfoandtreatment.com/diabetes/diabetes-drug-avandia-safe-actos-study-1028285a" rel="alternate"></link><updated>2010-08-24T14:30:13Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-24:/diabetes/diabetes-drug-avandia-safe-actos-study-1028285a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;'s diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; was no riskier to the heart than a rival, U.S. researchers said on Tuesday, a finding that contradicts earlier studies and adds new fodder to the roiling debate over the drug's safety. The study of more t...</summary><category term="Health Care Issues"></category><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Insurance Industry"></category><category term="Insurance Carriers"></category><category term="Health and Medical Insurance Carriers"></category><category term="Health Care Plans"></category><category term="Medicare"></category><category term="Reuters Group plc"></category><category term="David Graham"></category><category term="WellPoint Inc."></category><category term="Takeda Pharmaceutical Co. Ltd."></category><category term="Paying for Health Care"></category><category term="Cardiovascular Medicine"></category><category term="Debra Wertz"></category></entry><entry><title>Gene variants put diabetics at risk of kidney disease</title><link href="http://diabetesinfoandtreatment.com/diabetes/gene-variants-put-diabetics-risk-kidney-disease-1028201a" rel="alternate"></link><updated>2010-08-24T13:30:09Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-24:/diabetes/gene-variants-put-diabetics-risk-kidney-disease-1028201a</id><summary type="html">&lt;div&gt;&lt;p&gt;HONG KONG (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Some diabetics are at risk of developing chronic kidney disease if they have mutations of a certain gene, a long-term study in &lt;a title="Hong Kong" href="/topic/Hong+Kong" &gt;Hong Kong&lt;/a&gt; has found. Kidney failure is an important cause of death for people with type 2 diabetes, and ethnic Chinese diabetics are more prone to developing chronic kidney disease than Caucasians. The finding would help identi...</summary><category term="Kidney Failure"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Kidney and Urologic Health"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Journal of the American Medical Association"></category><category term="Reuters Group plc"></category><category term="East Asia"></category><category term="Prince Charles"></category><category term="Tan Ee Lyn"></category></entry><entry><title>A look at recent recalls of medical products</title><link href="http://diabetesinfoandtreatment.com/diabetes/recalls-medical-products-1027151a" rel="alternate"></link><updated>2010-08-23T13:30:18Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-23:/diabetes/recalls-medical-products-1027151a</id><summary type="html">&lt;div id="subtitle"&gt;A look at some recent recalls in the &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; of prescription medicines and medical devices&lt;/div&gt;&lt;div&gt;&lt;p&gt;PRESCRIPTION DRUGS _&lt;a title="The Medicines Company" href="/topic/The+Medicines+Company" &gt;The Medicines Company&lt;/a&gt;, March 17, &lt;a title="Cleviprex" href="/topic/Cleviprex" &gt;Cleviprex&lt;/a&gt; (a calcium channel blocker to rapidly reduce high blood pressure). Stainless steel particles in some vials. _&lt;a title="Baxter Internation...</summary><category term="Consumer Protection"></category><category term="Product Recalls"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Covidien Ltd."></category><category term="Baxter International Inc."></category><category term="The Medicines Company"></category><category term="Teleflex Inc."></category><category term="Cleviprex"></category><category term="Hylenex"></category><category term="PediaCare"></category></entry><entry><title>Green leafy vegetables can cut risk of diabetes: study</title><link href="http://diabetesinfoandtreatment.com/diabetes/green-leafy-vegetables-cut-risk-diabetes-study-1025262a" rel="alternate"></link><updated>2010-08-20T15:00:08Z</updated><author><name>Reuters Life! Online Report</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-20:/diabetes/green-leafy-vegetables-cut-risk-diabetes-study-1025262a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt; Life!) - Eating more green leafy vegetables can significantly cut the risk of developing diabetes, scientists said on Friday. British researchers reviewed six earlier studies on links between diabetes and the consumption of fruits and vegetables and found eating an extra serving a day of vegetables like spinach, cabbage, and broccoli reduced adults' risk of getting type 2 diabetes by 14 percent. The findi...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Fruits and Vegetables"></category><category term="Diet and Nutrition"></category><category term="Healthy Eating"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Obesity"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="East Asia"></category><category term="Oceania"></category><category term="Nordic Countries"></category><category term="Imperial College London"></category><category term="University of Leicester"></category><category term="Jim Mann"></category><category term="Belinda Goldsmith"></category><category term="Kate Kelland"></category><category term="London (England)"></category><category term="Body Weight"></category><category term="Genevra Pittman"></category><category term="Patrice Carter"></category><category term="Dagfinn Aune"></category><category term="Edgar National Center for Diabetes and Obesity Research"></category></entry><entry><title>Green leafy veg reduces diabetes risk - study</title><link href="http://diabetesinfoandtreatment.com/type-2-diabetes/green-leafy-veg-reduces-diabetes-risk-study-1024692a" rel="alternate"></link><updated>2010-08-20T03:15:36Z</updated><author><name>AFP European Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-20:/type-2-diabetes/green-leafy-veg-reduces-diabetes-risk-study-1024692a</id><summary type="html">&lt;div&gt;&lt;p&gt;Tucking into more spinach and other green leafy vegetables can reduce the risk of Type 2 diabetes, a study published on Friday by the &lt;a title="BMJ Publishing Group Ltd." href="/topic/BMJ+Publishing+Group+Ltd." &gt;British Medical Journal&lt;/a&gt; (BMJ) said. The research wades into a controversial area, and its authors caution more investigation is needed to confirm the findings. A team led by &lt;a title="Patrice Carter" href="/topic/Patrice+Carter" &gt;Patrice Carter&lt;/a&gt; at the &lt;a title="University...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Fruits and Vegetables"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Western Europe"></category><category term="University of Leicester"></category><category term="Patrice Carter"></category><category term="Ying Leng"></category><category term="Shanghai Institute of Materia"></category></entry><entry><title>Eye disorder common among diabetic adults</title><link href="http://diabetesinfoandtreatment.com/diabetes/eye-disorder-common-diabetic-adults-1016385a" rel="alternate"></link><updated>2010-08-10T13:30:12Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-10:/diabetes/eye-disorder-common-diabetic-adults-1016385a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Nearly 30 percent of &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; diabetics over the age of 40 may have a diabetes-related eye disorder, with 4 percent of this population affected severely enough that their vision is threatened, suggests a new study. The condition, known as diabetic retinopathy, involves damage to the eye's retina and is the leading cause of new cases of legal ...</summary><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Public Health Policy"></category><category term="Eyesight and Eye Health"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Social Issues"></category><category term="Aging and the Elderly"></category><category term="Journal of the American Medical Association"></category><category term="Reuters Group plc"></category><category term="Xinzhi Zhang"></category></entry><entry><title>Astra pays $198 mln to settle Seroquel lawsuits</title><link href="http://diabetesinfoandtreatment.com/diabetes/astra-pays-198-mln-settle-seroquel-lawsuits-1014868a" rel="alternate"></link><updated>2010-08-09T05:15:11Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-09:/diabetes/astra-pays-198-mln-settle-seroquel-lawsuits-1014868a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; pays $198 million to settle &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; lawsuits over antipsychotic drug&lt;/div&gt;&lt;div&gt;&lt;p&gt;AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug &lt;a title="Seroquel" href="/topic/Seroquel" &gt;Seroquel&lt;/a&gt;. AstraZeneca said Monday it has paid out to around 17,500 claimants regarding allegations the drug causes ...</summary><category term="Trials"></category><category term="Civil Trials"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="London"></category></entry><entry><title>Pregnancy-related diabetes likely to recur: study</title><link href="http://diabetesinfoandtreatment.com/gestational-diabetes/pregnancyrelated-diabetes-recur-study-1009597a" rel="alternate"></link><updated>2010-08-03T15:46:53Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-08-03:/gestational-diabetes/pregnancyrelated-diabetes-recur-study-1009597a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Pregnant women with a history of pregnancy-related diabetes, also called gestational diabetes, have a good chance of developing the condition again, suggests a large new study. Researchers found that the risk of having gestational diabetes during a future pregnancy increases with each previously affected one -- from 41 percent after the first to 57 percent after two pregnancies complicated by ge...</summary><category term="Family"></category><category term="Pregnancy and Childbirth"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Gestational Diabetes"></category><category term="Women's Health"></category><category term="Reuters Group plc"></category><category term="American Journal of Obstetrics &amp; Gynecology"></category><category term="Darios Getahun"></category><category term="Kaiser Permanente Southern California Medical Group"></category></entry><entry><title>Wireless sensor watches blood sugar for diabetics</title><link href="http://diabetesinfoandtreatment.com/type-1-diabetes/wireless-sensor-watches-blood-sugar-diabetics-1004739a" rel="alternate"></link><updated>2010-07-28T14:15:24Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-28:/type-1-diabetes/wireless-sensor-watches-blood-sugar-diabetics-1004739a</id><summary type="html">&lt;div&gt;&lt;p&gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Researchers have developed an implantable sensor that measures blood sugar continuously and transmits the information without wires -- a milestone, they said, in diabetes treatment. The device worked in one pig for more than a year and in another for nearly 10 months with no trouble, they reported in the journal Science Translational Medicine. It takes the diabetes field a step closer to development ...</summary><category term="Autoimmune Disorders"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Hypoglycemia"></category><category term="Type 1 Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Reuters Group plc"></category><category term="Clinical Immunology"></category><category term="Abbott Laboratories Inc."></category><category term="David Gough"></category><category term="Gerald E. McCormick"></category><category term="Smiths Group plc"></category><category term="GlySens Inc."></category></entry><entry><title>Adults born in famine show higher pre-diabetes risk</title><link href="http://diabetesinfoandtreatment.com/type-2-diabetes/adults-born-famine-show-higher-prediabetes-risk-999435a" rel="alternate"></link><updated>2010-07-22T13:45:31Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-22:/type-2-diabetes/adults-born-famine-show-higher-prediabetes-risk-999435a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Middle-aged adults born at the height of &lt;a title="China" href="/topic/China" &gt;China&lt;/a&gt;'s famine in the 1950s and 60s may have a greater risk of abnormally high blood sugar than those born just a few years earlier or later, a new study finds. The findings, reported in the journal Diabetes, support the theory that nutrition and growth during fetal development may affect the odds of developing ty...</summary><category term="Family"></category><category term="Parenting"></category><category term="Child Development"></category><category term="Infant Development"></category><category term="Diet and Nutrition"></category><category term="Vitamins and Supplements"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Diabetes Symptoms"></category><category term="Diabetic Diets"></category><category term="Type 2 Diabetes"></category><category term="Women's Health"></category><category term="Reuters Group plc"></category><category term="Prenatal Health, Labor and Delivery"></category><category term="East Asia"></category></entry><entry><title>Study raises hope for safer diabetes drugs</title><link href="http://diabetesinfoandtreatment.com/diabetes/study-raises-hope-safer-diabetes-drugs-998234a" rel="alternate"></link><updated>2010-07-21T15:30:50Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-21:/diabetes/study-raises-hope-safer-diabetes-drugs-998234a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;'s &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;, &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; researchers said on Wednesda...</summary><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Prediabetes"></category><category term="Type 2 Diabetes"></category><category term="Obesity"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Takeda Pharmaceutical Co. Ltd."></category><category term="Cardiovascular Medicine"></category><category term="Body Weight"></category><category term="Bruce Spiegelman"></category></entry><entry><title>FDA issues hold on much-debated Avandia study</title><link href="http://diabetesinfoandtreatment.com/diabetes/fda-issues-hold-muchdebated-avandia-study-998003a" rel="alternate"></link><updated>2010-07-21T09:45:22Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-21:/diabetes/fda-issues-hold-muchdebated-avandia-study-998003a</id><summary type="html">&lt;div id="subtitle"&gt;FDA bars new patients from enrolling in safety study of diabetes drug tied to heart risks&lt;/div&gt;&lt;div&gt;&lt;p&gt;Federal health officials say new patients should not be enrolled in a study of &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;'s controversial diabetes pill &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;, after experts last week said the drug increases heart risks. The &lt;a title="Food and Drug Administration" href="/topic/Food+and+D...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category></entry><entry><title>Earnings Preview: Bristol-Myers to discuss R&amp;D</title><link href="http://diabetesinfoandtreatment.com/diabetes/earnings-preview-bristolmyers-discuss-997911a" rel="alternate"></link><updated>2010-07-21T08:16:41Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-21:/diabetes/earnings-preview-bristolmyers-discuss-997911a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Bristol-Myers Squibb Company" href="/topic/Bristol-Myers+Squibb+Company" &gt;Bristol-Myers&lt;/a&gt; expected to focus on drug research progress, approval prospects in 2Q report&lt;/div&gt;&lt;div&gt;&lt;p&gt;Drugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results before the stock market opens Thursday. WHAT TO WATCH FOR: Analysts anticipate detailed updates on sev...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Western Europe"></category><category term="Bristol"></category><category term="Plavix"></category><category term="Thomson Reuters Corporation"></category><category term="Catherine Arnold"></category><category term="Medarex Inc."></category><category term="Jeffrey Holford"></category><category term="Immunotherapy"></category><category term="Onglyza"></category><category term="Jefferies International Ltd."></category></entry><entry><title>FDA warns Abbott on blood sugar monitors</title><link href="http://diabetesinfoandtreatment.com/diabetes/fda-warns-abbott-blood-sugar-monitors-997298a" rel="alternate"></link><updated>2010-07-20T16:00:45Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-20:/diabetes/fda-warns-abbott-blood-sugar-monitors-997298a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;U.S. Food and Drug Administration&lt;/a&gt; has warned &lt;a title="Abbott Laboratories Inc." href="/topic/Abbott+Laboratories+Inc." &gt;Abbott Laboratories&lt;/a&gt;' diabetes care unit about manufacturing problems at its &lt;a title="Alameda" href="/topic/Alameda" &gt;Alameda&lt;/a&gt;, &lt;a title="Ca...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Reuters Group plc"></category><category term="Abbott Laboratories Inc."></category><category term="Greg Miley"></category></entry><entry><title>Recall news</title><link href="http://diabetesinfoandtreatment.com/diabetes/recall-news-995976a" rel="alternate"></link><updated>2010-07-19T12:45:22Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-19:/diabetes/recall-news-995976a</id><summary type="html">&lt;div id="subtitle"&gt;Product recalls: dietary supplements&lt;/div&gt;&lt;div&gt;&lt;p&gt;The following recalls have been announced: _ &lt;a title="Good Health Inc." href="/topic/Good+Health+Inc." &gt;Good Health Inc.&lt;/a&gt;, of &lt;a title="Canutillo" href="/topic/Canutillo" &gt;Canutillo&lt;/a&gt;, &lt;a title="Texas" href="/topic/Texas" &gt;Texas&lt;/a&gt;, is recalling select lots of the dietary supplement Vialipro because they could contain a compound that is chemically similar to the erectile dysfunction drug sildenafil. This compound could i...</summary><category term="Consumer Protection"></category><category term="Product Recalls"></category><category term="Diet and Nutrition"></category><category term="Vitamins and Supplements"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Cholesterol"></category><category term="Vascular Disorders"></category><category term="High Blood Pressure"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Cardiovascular Medicine"></category><category term="Male Sexual Dysfunction"></category><category term="Canutillo"></category><category term="Good Health Inc."></category></entry><entry><title>Experts urge US to restrict drug Avandia</title><link href="http://diabetesinfoandtreatment.com/diabetes/experts-urge-restrict-drug-avandia-992172a" rel="alternate"></link><updated>2010-07-14T22:15:38Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-14:/diabetes/experts-urge-restrict-drug-avandia-992172a</id><summary type="html">&lt;div&gt;&lt;p&gt;A majority of members of a key advisory committee recommended  that the &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; government allow diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of heart problems, but only 12 of the 33-member expert panel voted to remove &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;Gl...</summary><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Western Europe"></category><category term="U.S. Senate Committee on Finance"></category><category term="Chuck Grassley"></category><category term="Max Baucus"></category><category term="Karen Riley"></category><category term="Mary Anne Rhyne"></category><category term="Cardiovascular Medicine"></category><category term="Ellen Strahlman"></category></entry><entry><title>Glaxo's diabetes drug Avandia faces moment of truth</title><link href="http://diabetesinfoandtreatment.com/diabetes/glaxos-diabetes-drug-avandia-faces-moment-truth-991616a" rel="alternate"></link><updated>2010-07-14T10:16:00Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-14:/diabetes/glaxos-diabetes-drug-avandia-faces-moment-truth-991616a</id><summary type="html">&lt;div&gt;&lt;p&gt;Diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems. The committee, convened at the request of the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt;, began its work on Tuesday as two US senators said Avandia manufacturer &lt;a title="Glaxo...</summary><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Western Europe"></category><category term="Chuck Grassley"></category><category term="Max Baucus"></category><category term="Mary Anne Rhyne"></category><category term="Cardiovascular Medicine"></category><category term="Thomas Marciniak"></category></entry><entry><title>Glaxo covered up diabetes drug's risks: US lawmakers</title><link href="http://diabetesinfoandtreatment.com/diabetes/glaxo-covered-diabetes-drugs-risks-lawmakers-990710a" rel="alternate"></link><updated>2010-07-13T13:15:37Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-13:/diabetes/glaxo-covered-diabetes-drugs-risks-lawmakers-990710a</id><summary type="html">&lt;div&gt;&lt;p&gt;British pharmaceutical giant &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt; hid the dangers of its top-selling diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; and secretly wrote scientific articles about it, two US lawmakers charged Tuesday. The allegations came as the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; (FDA) opened a two-day meeting of experts who ...</summary><category term="Politics"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="U.S. Senate Committee on Finance"></category><category term="Hamburg"></category><category term="Chuck Grassley"></category><category term="Max Baucus"></category><category term="Margaret Hamburg"></category></entry><entry><title>Indian doctors hail diabetes breakthrough</title><link href="http://diabetesinfoandtreatment.com/diabetes/indian-doctors-hail-diabetes-breakthrough-990564a" rel="alternate"></link><updated>2010-07-13T11:16:33Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-13:/diabetes/indian-doctors-hail-diabetes-breakthrough-990564a</id><summary type="html">&lt;div&gt;&lt;p&gt;Indian scientists said Tuesday they had made a breakthrough that could lead to diabetics needing to inject themselves only once a month or less, rather than every day. Researchers at the &lt;a title="National Institute of Immunology" href="/topic/National+Institute+of+Immunology" &gt;National Institute of Immunology&lt;/a&gt; in &lt;a title="New Delhi" href="/topic/New+Delhi" &gt;New Delhi&lt;/a&gt; said they had successfully concluded a two-year trial on mice, rats and rabbits of a drug which slowly releases i...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Sciences"></category><category term="South Asia"></category><category term="New Delhi"></category><category term="National Institute of Immunology"></category><category term="Anoop Misra"></category><category term="Diabetes Foundation"></category></entry><entry><title>Glaxo withheld info on diabetes drug's risks: US lawmakers</title><link href="http://diabetesinfoandtreatment.com/diabetes/glaxo-withheld-info-diabetes-drugs-risks-lawmakers-990565a" rel="alternate"></link><updated>2010-07-13T11:16:38Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-13:/diabetes/glaxo-withheld-info-diabetes-drugs-risks-lawmakers-990565a</id><summary type="html">&lt;div&gt;&lt;p&gt;UK pharmaceutical giant &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt; kept the dangers of its top-selling diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday. The allegations came as the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; (FDA) opened a two-day meeting of ex...</summary><category term="Politics"></category><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="U.S. Senate Committee on Finance"></category><category term="Hamburg"></category><category term="Chuck Grassley"></category><category term="Max Baucus"></category><category term="Margaret Hamburg"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Glaxo 'withheld info on diabetes drug's heart risks'</title><link href="http://diabetesinfoandtreatment.com/diabetes/glaxo-withheld-info-diabetes-drugs-heart-risks-990328a" rel="alternate"></link><updated>2010-07-13T08:16:32Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-13:/diabetes/glaxo-withheld-info-diabetes-drugs-heart-risks-990328a</id><summary type="html">&lt;div&gt;&lt;p&gt;British pharmaceutical giant &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt; withheld from &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; drug safety regulators information about the possible dangers of top-selling diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;, a report in the US press said Tuesday. The allegation was made in the &lt;a title="The Wall Street Journal" href="/topic/The+Wall+Street+Journal" &gt;Wall Street ...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category></entry><entry><title>Glaxo withheld info on diabetes drug's heart risks: report</title><link href="http://diabetesinfoandtreatment.com/diabetes/glaxo-withheld-info-diabetes-drugs-heart-risks-report-990311a" rel="alternate"></link><updated>2010-07-13T08:15:52Z</updated><author><name>AFP American Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-13:/diabetes/glaxo-withheld-info-diabetes-drugs-heart-risks-report-990311a</id><summary type="html">&lt;div&gt;&lt;p&gt;British pharmaceutical giant &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt; withheld from &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; drug safety regulators information about the possible dangers of top-selling diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;, a report in the US press said Tuesday. The allegation was made in the &lt;a title="The Wall Street Journal" href="/topic/The+Wall+Street+Journal" &gt;Wall Street ...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category></entry><entry><title>U.S. meeting nears on risks of Glaxo diabetes drug</title><link href="http://diabetesinfoandtreatment.com/diabetes/meeting-nears-risks-glaxo-diabetes-drug-990016a" rel="alternate"></link><updated>2010-07-13T01:30:15Z</updated><author><name>Reuters US Online Report Top News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-13:/diabetes/meeting-nears-risks-glaxo-diabetes-drug-990016a</id><summary type="html">&lt;div&gt;&lt;p&gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A heated three-year safety debate about a &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline Plc&lt;/a&gt; diabetes pill reaches a climax this week as opponents and backers face off at a &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; meeting that will help decide the drug's fate. A panel of scientific experts meets later Tuesday and again Wednesday to consider...</summary><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Reuters Group plc"></category><category term="Barack Obama"></category><category term="Takeda Pharmaceutical Co. Ltd."></category><category term="Cardiovascular Medicine"></category><category term="Thomas Marciniak"></category></entry><entry><title>From texting to apps, using cell phones for health</title><link href="http://diabetesinfoandtreatment.com/diabetes/texting-apps-cell-phones-health-989540a" rel="alternate"></link><updated>2010-07-12T12:32:09Z</updated><author><name>AP Features</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-12:/diabetes/texting-apps-cell-phones-health-989540a</id><summary type="html">&lt;div&gt;&lt;p&gt;What if my blood sugar's too high today? Is it time for my blood pressure pill? With nagging text messages or more customized two-way interactions, researchers are trying to harness the power of cell phones to help fight chronic diseases. "I call it medical minutes," says &lt;a title="Richard Katz" href="/topic/Richard+Katz" &gt;Dr. Richard Katz&lt;/a&gt; of &lt;a title="The George Washington University Hospital" href="/topic/The+George+Washington+University+Hospital" &gt;George Washington University Hosp...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Technology"></category><category term="Electronics"></category><category term="Communications Products"></category><category term="Consumer Electronics"></category><category term="Cellular Phones"></category><category term="Medical Technology"></category><category term="Health Information Technology"></category><category term="Medicaid"></category><category term="The Associated Press"></category><category term="Lauran Neergaard"></category><category term="Richard Katz"></category><category term="The George Washington University Hospital"></category><category term="Texting and MMS"></category><category term="Electronic Health and Medical Records"></category><category term="Tyrone Harvey"></category></entry><entry><title>Record-breaking pilot takes to the skies for diabetes</title><link href="http://diabetesinfoandtreatment.com/type-1-diabetes/recordbreaking-pilot-takes-skies-diabetes-988499a" rel="alternate"></link><updated>2010-07-11T04:00:06Z</updated><author><name>Reuters Life! Online Report</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-11:/type-1-diabetes/recordbreaking-pilot-takes-skies-diabetes-988499a</id><summary type="html">&lt;div&gt;&lt;p&gt;PARIS (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt; Life!) - A former &lt;a title="Royal Air Force of the United Kingdom" href="/topic/Royal+Air+Force+of+the+United+Kingdom" &gt;Royal Air Force&lt;/a&gt; pilot with diabetes is preparing to break another record by touching down in all 50 U.S. states and show that the disease is no obstacle for enthusiasts who dream of flying. London-based &lt;a title="Douglas Cairns" href="/topic/Douglas+Cairns" &gt;Douglas Cairns&lt;/a&gt; starts hi...</summary><category term="Autoimmune Disorders"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 1 Diabetes"></category><category term="Middle East"></category><category term="Western Europe"></category><category term="Pacific Ocean"></category><category term="Southeast Asia"></category><category term="Reuters Group plc"></category><category term="Oceania"></category><category term="North Pole"></category><category term="Clinical Immunology"></category><category term="Royal Air Force of the United Kingdom"></category><category term="Scottish Highlands"></category><category term="Beechcraft Baron"></category><category term="Sophie Taylor"></category><category term="London (England)"></category><category term="Douglas Cairns"></category></entry><entry><title>Diabetes drug Avandia gets new setback ahead of US decision</title><link href="http://diabetesinfoandtreatment.com/diabetes/diabetes-drug-avandia-new-setback-decision-987687a" rel="alternate"></link><updated>2010-07-09T14:15:51Z</updated><author><name>AFP Global Edition</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-09:/diabetes/diabetes-drug-avandia-new-setback-decision-987687a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;'s blockbuster diabetes treatment &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; suffered a new setback Friday when &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; health officials offered more evidence of the drug's increased link to heart problems. A document released by the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administrat...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Thomas Marciniak"></category></entry><entry><title>FDA review spotlights heart risk of diabetes pill</title><link href="http://diabetesinfoandtreatment.com/diabetes/fda-review-spotlights-heart-risk-diabetes-pill-987317a" rel="alternate"></link><updated>2010-07-09T07:16:01Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-09:/diabetes/fda-review-spotlights-heart-risk-diabetes-pill-987317a</id><summary type="html">&lt;div id="subtitle"&gt;FDA scrutinizes &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;'s safety risks ahead of meeting to decide fate of diabetes pill&lt;/div&gt;&lt;div&gt;&lt;p&gt;A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug. The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;FDA&lt;/a&gt; posted an ...</summary><category term="Consumer Protection"></category><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Medicare"></category><category term="Capitol Hill"></category><category term="Western Europe"></category><category term="East Asia"></category><category term="David Graham"></category><category term="Takeda Pharmaceutical Co. Ltd."></category><category term="Cardiovascular Medicine"></category></entry><entry><title>European agency to review safety of GSK's Avandia</title><link href="http://diabetesinfoandtreatment.com/diabetes/european-agency-review-safety-gsks-avandia-987156a" rel="alternate"></link><updated>2010-07-09T03:30:13Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-09:/diabetes/european-agency-review-safety-gsks-avandia-987156a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Medicines Agency" href="/topic/European+Medicines+Agency" &gt;European Medicines Agency&lt;/a&gt; to review safety of &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;'s diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;The European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and dea...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="EMEA Committee for Medicinal Products for Human Use"></category></entry><entry><title>HealthBeat Cell Phones</title><link href="http://diabetesinfoandtreatment.com/photo/healthbeat-cell-phones-2316032p" rel="alternate"></link><updated>2010-07-12T12:06:52Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-12:/photo/healthbeat-cell-phones-2316032p</id><summary type="html">&lt;a title="Tyrone Harvey" href="/topic/Tyrone+Harvey" &gt;Tyrone Harvey&lt;/a&gt;, 43, of &lt;a title="Washington, DC" href="/topic/Washington%2c+DC" &gt;Washington&lt;/a&gt;, looks at the program on his cell phone that he uses to input his blood glucose levels and other diabetes related data while at &lt;a title="Howard University Hospital" href="/topic/Howard+University+Hospital" &gt;Howard University Hospital&lt;/a&gt; in Washington,  Friday, July 9, 2010. Harvey uses a cell phone to help manage his diabetes as part of a prog...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category></entry><entry><title>Diabesity Surgery</title><link href="http://diabetesinfoandtreatment.com/photo/diabesity-surgery-2313192p" rel="alternate"></link><updated>2010-07-07T14:08:36Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-07:/photo/diabesity-surgery-2313192p</id><summary type="html">&lt;a title="Cristina Iaboni" href="/topic/Cristina+Iaboni" &gt;Cristina Iaboni&lt;/a&gt; poses for a portrait in her home in &lt;a title="Bethany" href="/topic/Bethany" &gt;Bethany&lt;/a&gt;, &lt;a title="Connecticut" href="/topic/Connecticut" &gt;Conn.&lt;/a&gt;, on Saturday, June 12, 2010. Iaboni, a diabetic, has found a doctor who is testing weight loss surgery on diabetics who are merely overweight or a tad obese in an attempt to curb the chronic disease. Scientists in recent years have discovered that diabetes all but disapp...</summary><category term="Weight Loss"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Medical Treatments and Procedures"></category><category term="Surgery"></category><category term="Obesity"></category><category term="Sciences"></category><category term="Bethany"></category><category term="Bariatric Surgery"></category><category term="Body Weight"></category></entry><entry><title>OBESITY_DIABETES</title><link href="http://diabetesinfoandtreatment.com/photo/obesity_diabetes-1953619p" rel="alternate"></link><updated>2010-03-29T20:59:29Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-03-29:/photo/obesity_diabetes-1953619p</id><summary type="html">Graph shows counties that are in the top 20 percentile and bottom 20 percentile nationwide for both obesity and diabetes.
&lt;div id="copyright"&gt;&lt;div&gt;
        Copyright 2009  &lt;a href="http://www.ap.org"&gt;AP News&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Obesity"></category></entry><entry><title>Celebrities Support "Thirst For Life" And Join The 2009 Juvenile Diabetes Research...</title><link href="http://diabetesinfoandtreatment.com/photo/celebrities-support-thirst-life-join-2009-juvenile-diabetes-research-1930259p" rel="alternate"></link><updated>2010-03-30T04:39:25Z</updated><author><name>Globe Photos</name></author><id>tag:diabetesinfoandtreatment.com,2010-03-30:/photo/celebrities-support-thirst-life-join-2009-juvenile-diabetes-research-1930259p</id><summary type="html">Celebrities Support "Thirst For Life" And Join The 2009 &lt;a title="Juvenile Diabetes Research Foundation" href="/topic/Juvenile+Diabetes+Research+Foundation" &gt;Juvenile Diabetes Research Foundation&lt;/a&gt;'s "Walk To Cure Diabetes"   
&lt;a title="Dodger Stadium" href="/topic/Dodger+Stadium" &gt;Dodger Stadium&lt;/a&gt;, &lt;a title="Los Angeles" href="/topic/Los+Angeles" &gt;Los Angeles&lt;/a&gt;, CA  
11/08/09
SUGAR &lt;a title="Ray Leonard" href="/topic/Ray+Leonard" &gt;RAY LEONARD&lt;/a&gt; AND &lt;a title="Dorian Gregory" href="/topic...</summary><category term="Entertainment"></category><category term="Celebrity News"></category><category term="Movies"></category><category term="Biopics"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 1 Diabetes"></category><category term="Dodger Stadium"></category><category term="Ray Leonard"></category><category term="Dorian Gregory"></category></entry><entry><title>Diabetes Pregnancy</title><link href="http://diabetesinfoandtreatment.com/photo/diabetes-pregnancy-1831222p" rel="alternate"></link><updated>2010-03-31T12:43:00Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-03-31:/photo/diabetes-pregnancy-1831222p</id><summary type="html">&lt;a title="Lorenda Donaugh" href="/topic/Lorenda+Donaugh" &gt;Lorenda Donaugh&lt;/a&gt;, top, who was treated for gestational diabetes during her pregnancy, is seen with her two-week-old daughter Adelynn at their &lt;a title="Westerville" href="/topic/Westerville" &gt;Westerville&lt;/a&gt;, &lt;a title="Ohio" href="/topic/Ohio" &gt;Ohio&lt;/a&gt;, residence Tuesday, Sept. 29, 2009. Treating even mild diabetes that develops during pregnancy helps keep moms and babies from gaining too much weight and makes for easier deliveries, n...</summary><category term="Family"></category><category term="Pregnancy and Childbirth"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Gestational Diabetes"></category><category term="Women's Health"></category><category term="Prenatal Health, Labor and Delivery"></category><category term="Westerville"></category><category term="Lorenda Donaugh"></category></entry></feed>